NASDAQ:BIOC - Nasdaq - US09072V6002 - Common Stock - Currency: USD
TTM (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 28.13M | 25.86M | 61.25M | 27.46M | 5.53M | |||
Cost Of Goods | 39.79M | 28.44M | 37.76M | 21.34M | 10.98M | |||
Gross Profit | -11.67M | -2.58M | 23.48M | 6.12M | -5.45M | |||
Operating Expenses | 43.69M | 29.40M | 25.89M | 21.59M | 17.61M | |||
Research and Development | 8.98M | 6.16M | 4.96M | 5.22M | 4.70M | |||
Selling, General, and Administrative Expenses | 34.71M | 23.24M | 20.93M | 16.37M | 12.91M | |||
Operating Income | -55.35M | -31.98M | -2.41M | -15.47M | -23.06M | |||
Interest Income/Expense | -464.00K | -316.00K | -290.00K | -240.00K | -250.00K | |||
Other Income/Expense | N/A | 87.00K | 0.00 | -2.10M | -1.83M | |||
Income Before Taxes | -53.11M | -32.21M | -2.70M | -17.81M | -25.14M | |||
Income Tax | -125.00K | -125.00K | 125.00K | 0.00 | 0.00 | |||
Net Income | -52.99M | -32.09M | -2.82M | -17.81M | -25.26M | |||
EBITDA | -53.52M | -30.33M | -879.00K | -14.38M | -22.13M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -90.31 | -56.78 | -5.73 | -1.50 | -12.20 | |||
Non GAAP EPS | N/A | -43.07 | -0.10 | -1.89 | N/A | |||
Statistics | ||||||||
Gross Profit Margin | -41.48% | -9.99% | 38.34% | 22.29% | -98.55% | |||
Profit Margin | -188.38% | -124.09% | -4.61% | -64.86% | -456.78% | |||
Operating Profit Margin | -196.79% | -123.69% | -3.93% | -56.34% | -417.00% |
All data in USD